We are live on
!
Find out more
UIM
USS Investment Management Portfolio holdings
AUM
$25.6B
1-Year Est. Return
30.22%
This Fund
S&P 500
This Quarter
Est. Return
-0.19%
1 Year Est. Return
+30.22%
3 Year Est. Return
+85.33%
5 Year Est. Return
+111.9%
10 Year Est. Return
+432.34%
AUM
$25.6B
AUM Growth
+$4.05B
(+19%)
Cap. Flow
+$4.67B
Cap. Flow
% of AUM
18.26%
Top 10 Holdings %
Top 10 Hldgs %
52.84%
Holding
523
New
15
Increased
358
Reduced
32
Closed
11
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.93B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.82B |
| 3 |
KLA
KLAC
|
+$165M |
| 4 |
Amazon
AMZN
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$88.1M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$89.8M |
| 2 |
iShares MSCI South Korea ETF
EWY
|
+$85.2M |
| 3 |
S&P Global
SPGI
|
+$66.2M |
| 4 |
Aon
AON
|
+$59.6M |
| 5 |
Marriott International
MAR
|
+$55.1M |
Sector Composition
| 1 | Technology | 21.43% |
| 2 | Consumer Discretionary | 8.8% |
| 3 | Financials | 8.37% |
| 4 | Industrials | 5.61% |
| 5 | Healthcare | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Cellebrite
CLBT
$3.85B
| $746K | ﹤0.01% |
54,141
+3,513
| +7% | +$52.9K |
|
502
monday.com
MNDY
$3.37B
| $657K | ﹤0.01% |
9,509
+524
| +6% | +$50.3K |
|
503
Frontline
FRO
$8.11B
| $620K | ﹤0.01% |
17,659
| – | – |
|
504
Teck Resources
TECK
$27.3B
| $606K | ﹤0.01% |
11,717
| – | – |
|
505
GE Vernova
GEV
$285B
| $601K | ﹤0.01% |
689
| – | – |
|
506
Hafnia
HAFN
$3.63B
| $576K | ﹤0.01% |
74,826
| – | – |
|
507
Cummins
CMI
$89.8B
| $286K | ﹤0.01% |
532
| – | – |
|
508
Archer Daniels Midland
ADM
$40.9B
| $266K | ﹤0.01% |
3,655
| – | – |
|
509
RB Global
RBA
$20.7B
| $259K | ﹤0.01% |
+2,696
| New | +$286K |
|
510
Magna International
MGA
$18.1B
| $254K | ﹤0.01% |
+4,588
| New | +$262K |
|
511
Ingersoll Rand
IR
$32.4B
| $233K | ﹤0.01% |
2,914
| – | – |
|
512
ODDITY Tech
ODD
$752M
| $196K | ﹤0.01% |
14,633
+880
| +6% | +$22.1K |
|
513
Aaon
AAON
$9.34B
| – | – |
-16,829
| Closed | -$1.28M |
|
514
A.O. Smith
AOS
$8.11B
| – | – |
-40,423
| Closed | -$2.7M |
|
515
Aptiv
APTV
$12.4B
| – | – |
-43,236
| Closed | -$3.29M |
|
|
CYBR
516
DELISTED
CyberArk
CYBR
| – | – |
-8,369
| Closed | -$3.73M |
|
517
Hubbell
HUBB
$25.8B
| – | – |
-9,581
| Closed | -$4.26M |
|
518
IDEX
IEX
$16.8B
| – | – |
-15,585
| Closed | -$2.77M |
|
519
Itron
ITRI
$3.79B
| – | – |
-20,234
| Closed | -$1.88M |
|
520
Pentair
PNR
$10.3B
| – | – |
-21,657
| Closed | -$2.26M |
|
521
RenaissanceRe
RNR
$13.6B
| – | – |
-18,107
| Closed | -$5.09M |
|
522
Union Pacific
UNP
$178B
| – | – |
-21,137
| Closed | -$4.89M |
|
523
Veralto
VLTO
$23B
| – | – |
-33,523
| Closed | -$3.34M |
|
Similar funds
VAI
KK
SO
USS Investment Management's Q1 2026 Portfolio in Review
As of Q1 2026, USS Investment Management held 523 positions worth $25.6B, up 19% from $21.5B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
USS Investment Management deployed $4.67B of net new capital in Q1 2026, opening 15 new positions and adding to 358 existing holdings. Its largest new stake was AstraZeneca: 255,467 shares worth $49.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was UnitedHealth, an estimated $89.8M trimmed.
- USS Investment Management's largest Q1 2026 buy was AstraZeneca: 255,467 shares worth $49.6M.
- USS Investment Management added most to Vanguard S&P 500 ETF in Q1 2026, an estimated $1.93B increase.
- USS Investment Management's biggest Q1 2026 reduction was UnitedHealth, cutting an estimated $89.8M.
- USS Investment Management fully exited RenaissanceRe in Q1 2026, selling an estimated $5.09M.
- USS Investment Management's ten largest holdings make up 53% of its $25.6B portfolio in Q1 2026.
- USS Investment Management opened 15 new positions and closed 11 in Q1 2026.
- USS Investment Management's portfolio value rose 19% quarter-over-quarter to $25.6B.
Based on USS Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.